Efficacy of lentiviral-mediated transfection of hTSHR in poorly differentiated thyroid carcinoma cell line

Nuclear Medicine and Biology

Volumn 40, Issue 4, 2013, Pages 576-580

  Cheng, Weiwei ^a   Fu, Hongliang ^a   Feng, Fang ^a   Ma, Chao ^a   Li, Jianing ^a   Chen, Suyun ^a   Wang, Hui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Differentiated thyroid cancer; Follicular thyroid cancer cell line; Lentivirus vector; Radioiodine; Thyrotropin receptor

Indexed keywords

GREEN FLUORESCENT PROTEIN; IODIDE; IODINE 125; LENTIVIRUS VECTOR; SODIUM IODIDE SYMPORTER; THYROGLOBULIN; THYROID PEROXIDASE; THYROTROPIN RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG UPTAKE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; POORLY DIFFERENTIATED THYROID CANCER; PROTEIN EXPRESSION; RADIOACTIVITY; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IODIDE PEROXIDASE; IODINE RADIOISOTOPES; LENTIVIRUS; ORGAN SPECIFICITY; RECEPTORS, THYROTROPIN; RNA, MESSENGER; SYMPORTERS; THYROGLOBULIN; THYROID NEOPLASMS; TRANSFECTION;

EID: 84876712965     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2012.12.004     Document Type: Article

References (27)

1. Woodrum D.T., Gauger P.G. Role of 131I in the treatment of well differentiated thyroid cancer. J Surg Oncol 2005, 89:114-121.
2. Jeong H., Kim Y.R., Kim K.N., Choe J.G., Chung J.K., Kim M.K. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line. Nucl Med Biol 2006, 33:875-882.
3. Walter M.A., Wild D., Rasch H., Müller-Brand J., Müller B., Bilz S. Coregistered iodine-131 single photon emission computed tomography/computed tomography reveals dedifferentiation in a metastatic follicular thyroid carcinoma. Thyroid 2006, 16:1063-1064.
4. Xing M., Usadel H., Cohen Y., Tokumaru Y., Guo Z., Westra W.B., et al. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. Cancer Res 2003, 63:2316-2321.
5. 131I pretreatment. Nucl Med Biol 2011, 38:1053-1058.
6. Hoffmann S., Maschuw K., Hassan I., Wunderlich A., Lingelbach S., Ramaswamy A., et al. Functional thyrotropin receptor attenuates malignant phenotype of follicular thyroid cancer cells. Endocrine 2006, 30:129-138.
7. Fiszer-Kierzkowska A., Vydra N., Wysocka-Wycisk A., Kronekova Z., Jarzab M., Lisowska K.M., et al. Liposome-based DNA carriers may induce cellular stress response and change gene expression pattern in transfected cells. BMC Mol Biol 2011, 12:27.
8. Weiss S.J., Philp N.J., Grollman E.F. Iodide transport in a continuous line of cultured cells from rat thyroid. Endocrinology 1984, 114:1090-1098.
9. Tuncel M., Aydin D., Yaman E., Tazebay U.H., Güç D., Doǧan A.L., et al. The comparative effects of gene modulators on thyroid specific genes and radioiodine uptake. Cancer Biother Radiopharm 2007, 22:443-449.
10. Mátrai J., Chuah M.K., VandenDriessche T. Recent advances in lentiviral vector development and applications. Mol Ther 2010, 18:477-490.
11. Ke C.C., Hsieh Y.-J., Hwu L., Wang F.-H., Chen F.-D., Chu L.-S., et al. Evaluation of lentiviral-mediated expression of sodium iodine symporter in anaplastic thyroid cancer and the efficacy of in vivo imaging and therapy. J Oncol 2011, 2011:178967.
12. Derwahl M., Broecker M., Aeschimann S., Schatz H., Studer H. Malignant transformation of rat thyroid cells transfected with the human TSH receptor cDNA. Biochem Biophys Res Commun 1992, 183:220-226.
13. Clark O.H., Gerend P.L. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms. J Clin Endocrinol Metab 1985, 61:773-778.
14. Duh Q.Y., Siperstein A.E., Miller R.A., Sancho J.J., Demeure M.J., Clark O.H. Epidermal growth factor receptors and adenylate cyclase activity in human thyroid tissues. World J Surg 1990, 14:410-419.
15. Wyllie F.S., Dawson T., Bond J.A., Goretzki P., Game S., Prime S., et al. Correlated abnormalities of transforming growth factor-beta 1 response and p53 expression in thyroid epithelial cell transformation. Mol Cell Endocrinol 1991, 76:13-21.
16. Ness G.O., Haugen D.R., Varhaug J.E., Akslen L.A., Lillehaug J.R. Cytoplasmic localization of EGF receptor in papillary thyroid carcinomas: association with the 150-kDa receptor form. Int J Cancer 1996, 65:161-167.
17. Masuda H., Sugenoya A., Kobayashi S., Kasuga Y., Iida F. Epidermal growth factor receptor on human thyroid neoplasms. World J Surg 1988, 12:616-622.
18. Hoelting T., Tezelman S., Siperstein A.E., Duh Q.Y., Clark O.H. Thyrotropin stimulates invasion and growth of follicular thyroid cancer cells via PKC- rather than PKA-activation. Biochem Biophys Res Commun 1993, 195:1230-1236.
19. Hölting T., Zielke A., Siperstein A.E., Clark O.H., Duh Q.Y. Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines. J Clin Endocrinol Metab 1994, 79:806-813.
20. Derwahl M., Kuemmel M., Goretzki P., Schatz H., Broecker M. Expression of the human TSH receptor in a human thyroid carcinoma cell line that lacks an endogenous TSH receptor: growth inhibition by cAMP. Biochem Biophys Res Commun 1993, 191:1131-1138.
21. Broecker M., Mayr G.W., Derwahl M. Suppression of thyrotropin receptor-G protein-phospholipase C coupling by activation of protein kinase C in thyroid carcinoma cells. Endocrinology 1997, 138:3787-3796.
22. Tepmongkol S., Keelawat S., Honsawek S., Ruangvejvorachai P. Rosiglitazone effect on radioiodine uptake in thyroid carcinoma patients with high thyroglobulin but negative total body scan: a correlation with the expression of peroxisome proliferator-activated receptor-gamma. Thyroid 2008, 18:697-704.
23. Lee Y.J., Chung J.K., Shin J.H., Kang J.H., Jeong J.M., Lee D.S., et al. In vitro and in vivo properties of a human anaplastic thyroid carcinoma cell line transfected with the sodium iodide symporter gene. Thyroid 2004, 14:889-895.
24. Twyffels L., Massart C., Golstein P.E., Raspe E., Van Sande J., Dumont J.E., et al. Pendrin: the thyrocyte apical membrane iodide transporter?. Cell Physiol Biochem 2011, 28:491-496.
25. Wolff J. What is the role of pendrin?. Thyroid 2005, 15:346-348.
26. Gillam M.P., Sidhaye A.R., Lee E.J., Rutishauser J., Stephan C.W., Kopp P. Functional characterization of pendrin in a polarized cell system. Evidence for pendrin-mediated apical iodine efflux. J Biol Chem 2004, 279:13004-13010.
27. Huang M., Batra R.K., Kogai T., Lin Y.Q., Hershman J.M., Lichtenstein A., et al. Ectopic expression of the thyroperoxidase gene augments radioiodide uptake and retention mediated by the sodium iodide symporter in non-small cell lung cancer. Cancer Gene Ther 2001, 8:612-618.